HSA — authorised 3 June 1971
- Marketing authorisation holder: DAVA PHARMS INC
- Status: likely_approved
HSA authorised Pyrazinamide on 3 June 1971
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 3 June 1971.
DAVA PHARMS INC holds the Singaporean marketing authorisation.